Theor Med Bioeth. 2011 Aug;32(4):229-43. doi: 10.1007/s11017-011-9179-8.

The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment.

Source

Department of Bioethics Clinical Center, National Institutes of Health, Building 10, Bethesda, MD 20892-1156, USA. fmiller@nih.gov

Abstract

It has been presumed within bioethics that the benefits and risks of treatments can be assessed independently of information disclosure to patients as part of the informed consent process. Research on placebo and nocebo effects indicates that this is not true for symptomatic treatments. The benefits and risks that patients experience from symptomatic treatments can be shaped powerfully by information about these treatments provided by clinicians. In this paper we discuss the implications of placebo and nocebo research for risk-benefit assessment and informed consent.

PMID:: 21479794; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Research Support, N.I.H., Intramural

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Patient Rights - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Study of cohort-specific consent and patient control in phase I cancer trials. [J Clin Oncol. 1998]
Study of cohort-specific consent and patient control in phase I cancer trials.
Daugherty CK, Ratain MJ, Minami H, Banik DM, Vogelzang NJ, Stadler WM, Siegler M. J Clin Oncol. 1998 Jul; 16(7):2305-12.
Review On informed consent. [Bull Pan Am Health Organ. 1990]
Review On informed consent.
Lara MC, de la Fuente JR. Bull Pan Am Health Organ. 1990; 24(4):419-24.
Review Informed consent and medical ethics. [Arch Ophthalmol. 1993]
Review Informed consent and medical ethics.
Finkelstein D, Smith MK, Faden R. Arch Ophthalmol. 1993 Mar; 111(3):324-6.
Autonomy, beneficence, and informed consent: rethinking the connections. I. [Cancer Invest. 1986]
Autonomy, beneficence, and informed consent: rethinking the connections. I.
Shatz D. Cancer Invest. 1986; 4(3):257-69.
Autonomy, beneficence, and informed consent: rethinking the connections. II. [Cancer Invest. 1986]
Autonomy, beneficence, and informed consent: rethinking the connections. II.
Shatz D. Cancer Invest. 1986; 4(4):353-61.

See reviews... See all...

Cited by 6 PubMed Central articles

Review Nocebo phenomena in medicine: their relevance in everyday clinical practice. [Dtsch Arztebl Int. 2012]
Review Nocebo phenomena in medicine: their relevance in everyday clinical practice.
Häuser W, Hansen E, Enck P. Dtsch Arztebl Int. 2012 Jun; 109(26):459-65. Epub 2012 Jun 29.
Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression. [BMC Med. 2012]
Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression.
Severus E, Seemuller F, Berger M, Dittmann S, Obermeier M, Pfennig A, Riedel M, Frangou S, Moller HJ, Bauer M. BMC Med. 2012 Jul 2; 10(1):67. Epub 2012 Jul 2.
The placebo response: science versus ethics and the vulnerability of the patient. [World Psychiatry. 2012]
The placebo response: science versus ethics and the vulnerability of the patient.
Benedetti F. World Psychiatry. 2012 Jun; 11(2):70-2.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The placebo phenomenon and medical ethics: rethinking the relationship between i...
The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment.
Theor Med Bioeth. 2011 Aug ;32(4):229-43. doi: 10.1007/s11017-011-9179-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: